0,1,2,3,4,5,6,7,8
Table 1,,,,,,,,
,Patient characteristics by the time-averaged serum uric acid groups.,,,,,,,
Variables,"Total
(N = 1738)",<5.5 (N = 213),5.5–6.4 (N = 400),6.5–7.4 (N = 493),7.5–8.4 (N = 371),≥8.5 (N = 261),P,N (%)
"Age, y",56 ± 13,57 ± 14,57 ± 13,56 ± 12,56 ± 13,54 ± 13,0.012,1738 (100)
"Men (N, %)",952 (54.8),102 (47.9),192 (48.0),277 (56.2),216 (58.2),165 (63.2),<0.001,1738 (100)
"BMI, kg/m2",22.8 ± 3.3,22.1 ± 3.4,22.5 ± 3.1,22.8 ± 3.2,22.9 ± 3.4,23.4 ± 3.3,<0.001,1652 (95.0)
"SBP, mm Hg",138 ± 21,135 ± 24,139 ± 20,138 ± 20,139 ± 20,138 ± 22,0.273,1633 (93.9)
"DBP, mm Hg",77 ± 12,76 ± 12,77 ± 12,77 ± 12,78 ± 13,77 ± 12,0.031,1652 (95.0)
"Hb, g/dL",10.6 ± 1.3,10.6 ± 1.3,10.5 ± 1.4,10.8 ± 1.3,10.5 ± 1.3,10.8 ± 1.3,0.004,1732 (99.7)
"HbA1c, %",6.3 ± 2.1,7.0 ± 1.6,6.4 ± 2.2,6.4 ± 1.4,6.3 ± 1.4,6.2 ± 2.1,0.040,949 (54.6)
"Ca, mg/dL",8.8 ± 0.9,8.9 ± 0.9,8.8 ± 0.9,8.8 ± 0.9,8.8 ± 0.8,8.7 ± 0.9,0.677,1717 (98.8)
"P, mg/dL",5.0 ± 1.5,4.4 ± 1.4,4.8 ± 1.4,5.1 ± 1.4,5.1 ± 1.5,5.5 ± 1.6,<0.001,1718 (98.8)
"Total protein, g/dL",6.7 ± 0.6,6.7 ± 0.7,6.6 ± 0.7,6.7 ± 0.6,6.7 ± 0.6,6.7 ± 0.6,<0.001,1710 (98.4)
"Albumin, g/dL",3.8 ± 0.5,3.8 ± 0.5,3.7 ± 0.5,3.8 ± 0.4,3.9 ± 0.4,4.0 ± 0.4,<0.001,1710 (98.4)
"Chol, mg/dL",162 ± 39,164 ± 40,164 ± 40,161 ± 39,160 ± 38,160 ± 37,0.512,1663 (95.7)
"TG, mg/dL",132 ± 97,123 ± 81,136 ± 130,126 ± 80,125 ± 79,150 ± 97,0.010,1469 (84.5)
"LDL, mg/dL",97 ± 32,96 ± 31,92 ± 32,89 ± 33,87 ± 32,87 ± 32,0.057,1297 (74.6)
"HDL, mg/dL",42 ± 13,43 ± 14,42 ± 14,42 ± 13,42 ± 14,40 ± 12,0.181,1386 (79.7)
"hs-CRP, mg/dL",1.3 ± 7.2,1.5 ± 8.0,1.3 ± 5.2,1.4 ± 8.3,1.6 ± 9.0,0.7 ± 2.7,0.683,1428 (82.2)
"SGA (malnourished, %)",207 (13.3),32 (16.6),51 (14.3),69 (15.8),37 (11.0),18 (7.9),0.019,1551 (89.2)
"Dialysis type (HD, %)",1087 (62.5),100 (46.9),218 (54.5),317 (64.3),256 (69.0),196 (75.1),<0.001,2108 (100)
Total Kt/V (per week),1.55 ± 0.45,1.64 ± 0.52,1.64 ± 0.65,1.55 ± 0.39,1.51 ± 0.31,1.46 ± 0.32,<0.001,1267 (72.9)
"Dialysis duration, mo",36 (16–70),43 (15–84),35 (18–73),35 (15–69),40 (17–72),31 (13–59),0.686,1700 (97.8)
"Follow-up duration, mo",43.9 ± 14.7,43.5 ± 14.9,43.6 ± 15.1,43.5 ± 15.2,44.3 ± 14.0,44.5 ± 14.2,0.860,1738 (100)
Etiology of ESRD,,,,,,,0.009,
"DM (N, %)",649 (46.2),94 (56.3),135 (42.9),209 (51.6),125 (41.0),86 (40.6),,649 (46.2)
"HTN (N, %)",357 (25.4),35 (21.0),86 (27.3),95 (23.5),74 (24.3),67 (31.5),,357 (25.4)
"GN (N, %)",267 (19.0),26 (15.6),63 (20.0),59 (14.6),75 (24.6),44 (20.8),,267 (19.0)
Cystic disease,75 (5.3),5 (0.4),17 (1.2),13 (0.9),14 (1.0),7 (0.5),,75 (5.3)
Miscellaneous condition,56 (4.0),7 (0.5),14 (1.0),16 (1.1),11 (0.8),8 (0.6),,56 (4.0)
Comorbid conditions,,,,,,,,
"DM (N, %)",688 (49.2),101 (55.2),157 (47.4),212 (51.8),129 (45.9),89 (46.1),0.190,688 (49.2)
"CAD (N, %)",125 (9.7),17 (9.9),28 (9.2),38 (10.1),19 (7.3),23 (13.4),0.347,125 (9.7)
"PVD (N, %)",28 (2.2),5 (2.9),6 (2.0),8 (2.1),5 (1.9),4 (2.3),0.965,28 (2.2)
"CVD (N, %)",66 (5.1),6 (3.5),18 (5.9),18 (4.8),6 (2.3),18 (10.5),0.004,66 (5.1)
"CHF (N, %)",90 (7.0),14 (8.1),19 (6.2),30 (8.0),12 (4.6),15 (8.7),0.380,90 (7.0)
"Gout
(N, %)",80 (4.6),8 (3.8),19 (4.8),24 (4.9),13 (3.5),16 (6.1),0.583,80 (4.6)
"Tumor
(N, %)",40 (3.1),5 (2.9),10 (3.3),12 (3.2),6 (2.3),7 (4.1),0.890,40 (3.1)
"Uricosuric drugs (N, %)",1006 (57.9),133 (62.4),239 (59.8),287 (58.2),215 (58.0),132 (50.6),0.087,1006 (57.9)
"Antiuricosuric drugs (N, %)",1509 (86.8),176 (82.6),346 (86.5),431 (87.4),320 (86.3),236 (90.4),0.163,1509 (86.8)
BMI = body mass,"index, Ca = calcium, CAD = coronary artery disease, CHF = congestive heart",,,"failure, Chol = cholesterol, CVD = cerebrovascular disease, DBP = diastolic blood pressure, DM = diabetes,",,,,
